Psilocybin for Depression: From Credibility to Feasibility, What's Missing?
Psilocybin has been suggested as a promising transdiagnostic treatment strategy for a wide range of psychiatric disorders. Recent findings showed that psychedelic-assisted/"psycholitic" psychotherapy should provide significant and sustained alleviation of depressive symptoms. However, to d...
Saved in:
Main Authors: | Antonio Munafò (Author), Davide Arillotta (Author), Guido Mannaioni (Author), Fabrizio Schifano (Author), Renato Bernardini (Author), Giuseppina Cantarella (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psilocybin's Emerging Role in Combating Depressive Disorder
by: Anna Jaremek, et al.
Published: (2023) -
Psilocybin as a new way for depression treatment
by: Mateusz Maciej Pawlicki, et al.
Published: (2024) -
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
by: Roberta Murphy, et al.
Published: (2022) -
Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
by: Gniewko Więckiewicz, et al.
Published: (2021) -
Rediscovering Psilocybin as an Antidepressive Treatment Strategy
by: Rene Zeiss, et al.
Published: (2021)